NLNathan L'EToile

Nathan L'EToile

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nathan L'EToile has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Candida auris in the neonatal intensive care unit

    by Nathan L’EToile, Thomas S. Murray


  • Open Access

    Empowering global disease surveillance with CURED: a tool for rapid identification of unique genomic biomarkers

    by Erin Theiller, Swetha Rajagopol, Stephanie Higgins, Dayanara I. Torres, T'NIa Napper, Bianca E. Galis, Arie Dash, Elizabeth Qian, Lauren Hamlette, Qianxuan She, et al.

    Rapid tracking of emerging pathogenic microorganisms is crucial for designing effective treatment, infection control, and prevention strategies. While whole-genome sequencing (WGS) offers the necessary granularity to track emerging clones, it remains prohibitively expensive at the scales needed to monitor with high resolution in real time. We present CURED (Classification Using Restriction Enzyme Diagnostics), which uses a training set of sequenced genomes to identify unique k-mers with restriction sites specific to a clonal lineage. CURED enables fast and inexpensive PCR-based diagnostic tests for surveillance or outbreak investigations with minimal use of WGS. Benchmarking against existing tools, CURED compares favorably and scales more efficiently than other k-mer search strategies. We validated and tested CURED in five distinct data sets: (i) previously identified biomarkers described for a methicillin-resistant Staphylococcus aureus (MRSA) clone in Rio de Janeiro, (ii) diagnostic alleles for different lineages in the USA300 MRSA clone, (ii) the extensively drug-resistant Acinetobacter baumannii Global Clone 1 lineage, (iv) toxigenic versus non-toxigenic Clostridioides difficile , and (v) circulating S. aureus clones in a neonatal intensive care unit (NICU). We implemented CURED as part of NICU infection prevention efforts and report the test’s speed, sensitivity, and specificity in a real-world setting. CURED is a scalable, multithreaded, memory-, and cost-efficient pipeline tailored for rapid clone detection and restriction site analysis. While particularly impactful for localized outbreak investigations and targeted surveillance, our preliminary work at the global scale suggests broader implementation is feasible. CURED is freely available at https://github.com/microbialARC/CURED . IMPORTANCE: Timely and cost-effective detection of emerging microbial clones is essential for infection prevention and public health surveillance. While whole-genome sequencing remains the gold standard for tracking microbial evolution and transmission, its cost, infrastructure requirements, and turnaround time limit its scalability, especially in resource-limited settings. CURED addresses this gap by enabling the development of inexpensive, PCR-based diagnostic assays informed by genomic data, without requiring further sequencing. By identifying lineage-specific restriction sites through a scalable and memory-efficient k-mer pipeline, CURED enables the translation of genome-scale insights into actionable diagnostics. This tool supports broader implementation of genomic-informed diagnostics in both local and global pathogen surveillance efforts.


  • Open Access

    Antimicrobial locks for the prevention of central line associated bloodstream infections in pediatric patients: a systematic review and network meta-analysis

    by Nathan L’EToile, Yun Li, Ericka Hayes, Susan E. Coffin

    Central-line-associated bloodstream infections (CLABSI) impart substantial morbidity and mortality worldwide Neonates and other pediatric patients with chr


  • Open Access

    Molecular Relatedness of Maternal and Neonatal Multidrug-Resistant Gram-Negative Colonization Isolates in Low and Middle-Income Countries: A Systematic Review.

    by Joycelyn A Dame, Gabrielle Obeng-Koranteng, Nathan L’eToile, Evelyn Amoah, Susan E Coffin, Adam J Ratner, Jonathan Strysko, Jiayin Zheng, Andrew P Steenhoff, Grace St. Cyr

    Background: Multidrug-resistant gram-negative (MDR-GN) sepsis is a significant cause of neonatal mortality in low- and middle-income countries (LMICs). The role of vertical transmission in neonatal MDR-GN colonization and thereby invasive infection remains unknown. Aim: To systematically review literature detailing molecular relatedness of maternal and neonatal MDR-GN colonization isolates in LMICs, characterizing extent of vertical transmission. Methods: Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, PubMed and Scopus databases were searched for LMIC literature reporting molecular evidence of MDR-GN concordance for mother-neonate dyads. Findings: Of 90 articles identified by the search, 11 met inclusion criteria. Findings demonstrated substantial MDR-GN colonization in dyads from LMICs, though with significant heterogeneity in sampling methods. From MDR-GN dyads, molecular methods rarely found relatedness. Many studies suggested horizontal transmission within the environment. Conclusion: In LMICs, maternal MDR-GN colonization rarely results in vertical transmission to neonates. However, literature remains scarce and further research is needed.

  • Open Access

    Pocapavir for neonatal enteroviral sepsis: limitations of rapid viral sequencing on treatment decisions

    by Nathan L'EToile, Sesh A. Sundararaman, Erin Theiller, Justin J. Miller, Ahmed M. Moustafa, Andrew P. Steenhoff, Audrey R. Odom John

    Background: Neonatal enterovirus infection can be severe and life-threatening, and there is ongoing interest in the development of antiviral compounds; however, their clinical efficacy has not been definitively proven. Case Summary: We describe a case of neonatal enterovirus infection treated with the investigational therapeutic pocapavir, a viral capsid inhibitor. We describe the medical decision-making regarding the choice to offer pocapavir therapy. Because of clinical uncertainty about whether pocapavir contributed to clinical improvement, we performed sequencing of the viral genome and modeled the pocapavir pocket-binding site for evidence of genetic and protein changes before or after the initiation of pocapavir that might confer antiviral resistance. Conclusion: This case and our findings reveal the challenges in interpreting sequence analysis of clinical enterovirus isolates to inform clinical decision-making regarding the use of pocapavir for the treatment of neonatal enterovirus.


  • Healthcare-Associated Gastroenteritis: Outbreak Report and Systematic Review of the Literature

    by Nathan L’eToile, Morgan A Zalot, Salma Sadaf, Nicole Wittmeyer, Anna Davis, Jordan Mick, Ericka Hayes, Kathleen A Gibbs, Susan E Coffin

    Healthcare-associated gastroenteritis continues to be associated with significant pediatric morbidity and mortality despite the introduction of rotavirus vaccines. Infection prevention (IP) measures are critical in mitigating outbreaks. We describe an outbreak of norovirus and effective IP strategies utilized and calculated the costs associated with the outbreak. To demonstrate the burden of these events, we conducted a systematic review of pediatric healthcare-associated gastroenteritis outbreaks since 1973 to describe changing epidemiologic trends. Twenty-four publications describing 27 outbreaks were included in the final analysis with 293 healthcare-associated cases. Rotavirus (14) and norovirus (7) outbreaks were most commonly described. Limitations include the retrospective nature of included reports, nonuniform data ascertainment and reporting among publications. Norovirus has replaced rotavirus as the most common etiology of healthcare-associated gastroenteritis outbreaks in North America, Europe, and Australia and New Zealand, since the introduction of rotavirus vaccines.


  • Open Access

    Report of an outbreak of enterovirus disease in a neonatal intensive care unit and a systematic review of the literature

    by Nathan L'EToile, Lindsay Brim, Susan Coffin, Ericka Hayes

    Neonatal enterovirus infections have the potential to cause devastating illness and death in this vulnerable age group. Existing evidence suggests that the incidence of enteroviral infections in the post-natal period may be higher than previously thought. Because neonates infected with enterovirus are at risk of severe sequelae, and healthcare-associated outbreaks in neonatal settings can occur, enteroviral infection in hospitalized neonates is a serious concern. Thus, it is essential to conduct surveillance for these infections and to deploy robust infection control measures once the virus has been detected in a neonatal care setting. Here, we report an outbreak of enterovirus in a neonatal intensive care unit (NICU) that was rapidly identified and contained, resulting in relatively few cases but requiring temporary closure of the unit. Additionally, we present our review of the literature describing the characteristics of enteroviral outbreaks in NICU and nursery settings to compare published outcomes of outbreaks to those of our outcome.


  • Sterile abscesses following administration of long-acting injectable rilpivirine for HIV

    by Nathan L'EToile, Elizabeth Lowenthal

    Long-acting injectable antiretroviral therapy for HIV has improved treatment satisfaction with mild injection site reactions reported. We describe a case of a young adult with sterile abscesses at the sites of two consecutive injections. This case describes a significant side effect noted during post-market roll-out.